Showing results (221-230 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|February 1, 2026
3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trialBenjamin Z Leder, Sabashini K Ramchand, Mackenzie Jordan, et al.
The Lancet. Diabetes & Endocrinology|January 26, 2026
Clinical features, investigation, and management of Addison's diseaseJiawen Dong, Stefanie Hahner, Irina Bancos, et al.
The Lancet. Diabetes & Endocrinology|January 31, 2026
Menopausal hormone treatment and breast cancerAnne Gompel, Richard Simcock
The Lancet. Diabetes & Endocrinology|December 13, 2025
Obesity in China: current progress and future prospectsXiong-Fei Pan, Zhong-Ze Fang, Lingli Zhang, et al.
The Lancet. Diabetes & Endocrinology|November 20, 2025
Adrenal tumour imaging: clinical, molecular, and radiomics perspectivesKarel Pacak, Michael A Blake, Ann T Sweeney, et al.
The Lancet. Diabetes & Endocrinology|February 8, 2024
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trialCarel W le Roux, Oren Steen, Kathryn J Lucas, et al.
The Lancet. Diabetes & Endocrinology|January 25, 2024
The impact of the COVID-19 pandemic and associated disruptions in health-care provision on clinical outcomes in people with diabetes: a systematic reviewJamie Hartmann-Boyce, Patrick Highton, Karen Rees, et al.
The Lancet. Diabetes & Endocrinology|October 21, 2023
Sex steroids and the female brain across the lifespan: insights into risk of depression and Alzheimer's diseaseClaudia Barth, Arielle Crestol, Ann-Marie G de Lange, et al.
Pageof 93